# Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis

> **NCT00355771** · PHASE4 · COMPLETED · sponsor: **Institut für Atemwegsforschung GmbH** · enrollment: 100 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Levocetirizine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00355771
- **Lead sponsor:** Institut für Atemwegsforschung GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2008-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355771, "Levocetirizine 5 mg: Reduction of Symptoms, Airway Resistance and Sleep Impairment in Persistent Allergic Rhinitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00355771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*